16-1220417-G-T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_021098.3(CACNA1H):​c.6485G>T​(p.Ser2162Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000261 in 1,531,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S2162S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000015 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.139

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22041255).
BP6
Variant 16-1220417-G-T is Benign according to our data. Variant chr16-1220417-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 582677.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.6485G>Tp.Ser2162Ile
missense
Exon 35 of 35NP_066921.2
CACNA1H
NM_001005407.2
c.6467G>Tp.Ser2156Ile
missense
Exon 34 of 34NP_001005407.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.6485G>Tp.Ser2162Ile
missense
Exon 35 of 35ENSP00000334198.7
CACNA1H
ENST00000569107.6
TSL:1
c.6500G>Tp.Ser2167Ile
missense
Exon 34 of 34ENSP00000454990.2
CACNA1H
ENST00000711493.1
c.6470G>Tp.Ser2157Ile
missense
Exon 34 of 34ENSP00000518778.1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152220
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000638
AC:
1
AN:
156824
AF XY:
0.0000115
show subpopulations
Gnomad AFR exome
AF:
0.0000915
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000145
AC:
2
AN:
1378862
Hom.:
0
Cov.:
35
AF XY:
0.00000147
AC XY:
1
AN XY:
680848
show subpopulations
African (AFR)
AF:
0.0000677
AC:
2
AN:
29552
American (AMR)
AF:
0.00
AC:
0
AN:
29648
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20504
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38088
South Asian (SAS)
AF:
0.00
AC:
0
AN:
72558
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46316
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5352
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1080242
Other (OTH)
AF:
0.00
AC:
0
AN:
56602
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152220
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41460
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.00000870
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Mar 06, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Nov 24, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.070
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
3.6
DANN
Benign
0.61
DEOGEN2
Benign
0.23
T
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.95
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.53
T
M_CAP
Pathogenic
0.79
D
MetaRNN
Benign
0.22
T
MetaSVM
Uncertain
0.13
D
MutationAssessor
Uncertain
2.0
M
PhyloP100
-0.14
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-2.1
N
REVEL
Uncertain
0.30
Sift
Benign
0.061
T
Sift4G
Benign
0.36
T
Polyphen
0.068
B
Vest4
0.13
MutPred
0.27
Loss of glycosylation at S2162 (P = 0.0012)
MVP
0.76
ClinPred
0.025
T
GERP RS
-1.8
Varity_R
0.059
gMVP
0.12
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs745906833; hg19: chr16-1270417; API